Effects of diflorasone topical: A Synthesis of Findings from 16 Studies
- Home
- Effects of diflorasone topical
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of diflorasone topical: A Synthesis of Findings from 16 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main Research Findings
Diflorasone diacetate, a topical corticosteroid, has shown effectiveness in treating various skin conditions. 7 Research has indicated its ability to reduce skin thickness, a common side effect of corticosteroid use. 7 This reduction in skin thickness is temporary and reversible. 7 Studies have also shown diflorasone diacetate to be effective in treating eczematous dermatoses, with over 80% of patients reporting improvement. 11 A single daily application demonstrated significant improvement within three weeks. 11 Furthermore, diflorasone diacetate has been found to be effective in treating childhood genital lichen sclerosus. 14 Its efficacy in treating acute and chronic dermatitis has also been established, with a 95% success rate observed over 21 days of therapy. 6 Notably, diflorasone diacetate has been proven to be as effective as fluocinonide in treating psoriasis and atopic/neurodermatitis. 5
Benefits and Risks
Benefits Summary
Diflorasone diacetate has shown promise in treating a range of skin conditions including eczematous dermatoses, childhood genital lichen sclerosus, and acute and chronic dermatitis. 11 14 6 It is generally safe for use and effectively reduces skin thickness. 7 6
Risks Summary
While generally safe, diflorasone diacetate can cause temporary burning and stinging sensations. 11 Like other potent topical steroids, it may cause local side effects such as skin atrophy, steroid acne, perioral dermatitis, hypopigmentation, hypertrichosis, and superinfections. 2 Prolonged use may lead to suppression of the hypothalamic-pituitary-adrenal (HPA) axis. 2 It should not be used under occlusion, in flexural areas, on the face, or in children. 2
Comparison Between Studies
Similarities
Most studies consistently demonstrate diflorasone diacetate’s effectiveness in treating various skin conditions. 7 11 14 6 Furthermore, these studies confirm its safety profile. 11 6
Differences
There are some discrepancies among studies regarding the specifics of diflorasone diacetate's effects and safety. 12 For instance, the study on allergic dermatitis highlighted its greater effectiveness when applied topically compared to oral or intraperitoneal administration. 12 Likewise, the skin thinning effect observed in some studies differs in magnitude and duration. 7 The incidence and severity of side effects also vary across studies. 11 It is essential to note that diflorasone diacetate is contraindicated in children. 2 These discrepancies suggest that the effects and safety of diflorasone diacetate might be influenced by factors such as the specific condition being treated, the patient’s characteristics, and the method of administration.
Consistency and Discrepancies in Results
The research findings generally support the notion that diflorasone diacetate is a valuable treatment option for a variety of skin conditions. 7 11 14 6 However, certain discrepancies exist, particularly regarding the most effective route of administration and the specific side effects. 12 11 These inconsistencies emphasize the need for further research to fully understand the optimal use of diflorasone diacetate for different skin conditions and patient demographics.
Cautions in Real-Life Applications
While promising, diflorasone diacetate’s use should be guided by a healthcare professional. 2 Its potential side effects, such as skin atrophy and HPA axis suppression, require careful monitoring, especially with prolonged use. 2 It should not be used in children or under occlusion, as these factors increase the risk of adverse effects. 2
Limitations of Current Research
The research on diflorasone diacetate is still in its early stages and some limitations exist. 2 Most studies involve animal models or small-scale clinical trials, limiting the generalizability of the findings to the broader population. 12 7 11 14 6 Furthermore, the long-term effects of diflorasone diacetate have not been extensively studied. 2
Future Research Directions
Further research is essential to better understand the benefits and risks of diflorasone diacetate. 2 Large-scale clinical trials are needed to confirm its efficacy and safety in diverse patient populations. 12 7 11 14 6 Long-term studies are also needed to investigate the potential long-term effects of diflorasone diacetate. 2 These research endeavors will help to clarify diflorasone diacetate’s position as a safe and effective treatment option for various skin conditions.
Conclusion
Diflorasone diacetate appears to be a promising treatment for various skin conditions, including eczematous dermatoses, childhood genital lichen sclerosus, and acute and chronic dermatitis. 11 14 6 While generally safe, it can cause temporary side effects like burning and stinging. 11 Its use should be monitored closely, particularly in children, and under occlusion. 2 More research is needed to further understand its long-term effects and to guide optimal treatment strategies. 2 Always consult a healthcare professional before using diflorasone diacetate or any other topical medication.
Benefit Keywords
Risk Keywords
Article Type
Author: RozmanT A
Language : German
Author: PrawerS E, KatzH I
Language : English
Author: LubachD, KietzmannM
Language : English
Author: TuriJ S, DanielsonD, WoltersomJ W
Language : English
Author: BluefarbS M, HowardF M, LeibsohnE, SchlagelC A, WexlerL
Language : English
Author: SchneiderW D
Language : German
[Development and regression of dermal corticosteroid atrophy. 1. Change in the skinfold thickness].
Author: LubachD, HinzE
Language : German
Author: SpencerS A, FenskeN A, BookbinderS A, VaseyF B
Language : English
Author: BäumerW, KrekelerS, DeVriesV C, NiedorfF, TschernigT, KietzmannM
Language : English
Author: HersleK, MobackenH
Language : English
Author: BäumerWolfgang, GorrGilbert, HoppmannJoachim, EhingerAndreas M, RundfeldtChris, KietzmannManfred
Language : English
Author: GreenLawrence, SadoffWendy
Language : English
Author: GarzonM C, PallerA S
Language : English
Author: ZackheimH S, Kashani-SabetM, AminS
Language : English
Author: SchaperKatrin, DickhautJeannette, JaptokLukasz, KietzmannManfred, MischkeReinhard, KleuserBurkhard, BäumerWolfgang
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.